Sanofi Consumer Healthcare India vs Peers
- Market cap
- ₹8,181 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹2,557.58 – ₹4,795.47
Sanofi Consumer Healthcare India ranks 1st by market capitalisation among 1 Drug Manufacturers - General companies tracked by ATS. Its largest peers are Sanofi Consumer Healthcare India. Its P/E of 22.5 compares with a peer median of 22.5.
Sanofi Consumer Healthcare India vs Drug Manufacturers - General peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Sanofi Consumer Healthcare India | 3,552.20 | -1.34% | 8,181 | 22.5 | 2.85 | 14.5% | +18.5% |
| Sanofi Consumer Healthcare India | 3,552.20 | -1.34% | 8,181 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
Sanofi Consumer Healthcare India peer comparison — frequently asked questions
Who are Sanofi Consumer Healthcare India's competitors?
Sanofi Consumer Healthcare India's listed peers in Drug Manufacturers - General include Sanofi Consumer Healthcare India, ranked here by market capitalisation.
How does Sanofi Consumer Healthcare India's P/E compare with its peers?
Sanofi Consumer Healthcare India trades at a P/E of 22.5, against a median of 22.5 across the 1 Drug Manufacturers - General peers shown.
Which is the largest company among Sanofi Consumer Healthcare India's peers?
By market capitalisation, the largest company in the group is Sanofi Consumer Healthcare India at ₹8,181 crore, against ₹8,181 crore for Sanofi Consumer Healthcare India.
Same Data For Peers
Trade Sanofi Consumer Healthcare India With ATS
Track SANOFICONR live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.